| Product Code: ETC9552850 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden Cyclooxygenase 2 Inhibitor Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden Cyclooxygenase 2 Inhibitor Market - Industry Life Cycle |
3.4 Sweden Cyclooxygenase 2 Inhibitor Market - Porter's Five Forces |
3.5 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.7 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Sweden Cyclooxygenase 2 Inhibitor Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of inflammatory conditions in Sweden |
4.2.2 Rising awareness about the benefits of cyclooxygenase 2 inhibitors for pain management |
4.2.3 Growing geriatric population requiring medication for chronic pain management |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and marketing of cyclooxygenase 2 inhibitors |
4.3.2 Potential side effects and safety concerns associated with long-term use of these inhibitors |
5 Sweden Cyclooxygenase 2 Inhibitor Market Trends |
6 Sweden Cyclooxygenase 2 Inhibitor Market, By Types |
6.1 Sweden Cyclooxygenase 2 Inhibitor Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Celecoxib, 2021- 2031F |
6.1.4 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rofecoxib, 2021- 2031F |
6.1.5 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Valdecoxib, 2021- 2031F |
6.1.6 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Amlodipine, 2021- 2031F |
6.1.7 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Sweden Cyclooxygenase 2 Inhibitor Market, By Types |
6.2.1 Overview and Analysis |
6.2.2 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Selective cox 2 inhibitor, 2021- 2031F |
6.2.3 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Non-selective cox 2 inhibitor, 2021- 2031F |
6.3 Sweden Cyclooxygenase 2 Inhibitor Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Osteoarthritis, 2021- 2031F |
6.3.3 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Rheumatoid arthritis, 2021- 2031F |
6.3.4 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Sweden Cyclooxygenase 2 Inhibitor Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Sweden Cyclooxygenase 2 Inhibitor Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.4 Sweden Cyclooxygenase 2 Inhibitor Market Revenues & Volume, By Others, 2021- 2031F |
7 Sweden Cyclooxygenase 2 Inhibitor Market Import-Export Trade Statistics |
7.1 Sweden Cyclooxygenase 2 Inhibitor Market Export to Major Countries |
7.2 Sweden Cyclooxygenase 2 Inhibitor Market Imports from Major Countries |
8 Sweden Cyclooxygenase 2 Inhibitor Market Key Performance Indicators |
8.1 Number of prescriptions for cyclooxygenase 2 inhibitors in Sweden |
8.2 Patient adherence rates to prescribed cyclooxygenase 2 inhibitors |
8.3 Number of clinical trials and research studies on the efficacy and safety of these inhibitors |
9 Sweden Cyclooxygenase 2 Inhibitor Market - Opportunity Assessment |
9.1 Sweden Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Sweden Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Types, 2021 & 2031F |
9.3 Sweden Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Sweden Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 Sweden Cyclooxygenase 2 Inhibitor Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Sweden Cyclooxygenase 2 Inhibitor Market - Competitive Landscape |
10.1 Sweden Cyclooxygenase 2 Inhibitor Market Revenue Share, By Companies, 2024 |
10.2 Sweden Cyclooxygenase 2 Inhibitor Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here